SPY305.55+1.23 0.40%
DIA255.27+0.98 0.39%
IXIC9,552.05+62.18 0.66%

CymaBay Therapeutics Q1 EPS $(0.190) Beats $(0.300) Estimate

CymaBay Therapeutics (NASDAQ:CBAY) reported quarterly losses of $(0.190) per share which beat the analyst consensus estimate of $(0.300) by 36.67 percent. This is a 48.65 percent increase over losses of $(0.370) per

Benzinga · 05/11/2020 20:04

CymaBay Therapeutics (NASDAQ:CBAY) reported quarterly losses of $(0.190) per share which beat the analyst consensus estimate of $(0.300) by 36.67 percent. This is a 48.65 percent increase over losses of $(0.370) per share from the same period last year.